Service 08 — Women's Health
Women's Health Hormone & Peptide Therapy
Women's health is a named core specialty at Newtropin. Through our partnership with a licensed 503A compounding pharmacy, we support providers treating menopause and perimenopause, PCOS, postpartum recovery, thyroid and metabolic concerns, and sexual wellness — with formulations commercial products cannot match.
Across Every Stage
Women’s health is not one protocol
The same symptom means different things at 35, 45, and 60. Our partner pharmacy supports providers with formulations matched to the stage and to the individual patient — not to a fixed commercial strength.
Perimenopause
The transition often begins in the early forties and can run for a decade. Fluctuating estradiol produces irregular cycles, sleep disruption, mood changes, and a shift in body composition toward central fat — frequently while lab values still read as normal.
Menopause & Beyond
Vasomotor symptoms, genitourinary syndrome, bone density loss, and accelerated skin collagen loss. Genitourinary symptoms are the most treatable cluster and the least raised — unlike hot flashes, they progress rather than resolve.
PCOS & Cycle Disorders
An endocrine and metabolic condition affecting an estimated 8–13% of reproductive-age women, driven in most cases by insulin resistance. Management targets the metabolic driver, androgenic symptoms, and endometrial protection.
Postpartum
The most abrupt hormonal shift any healthy adult experiences. Thyroid dysfunction and iron deficiency are common, frequently missed, and easily mistaken for normal postpartum fatigue.
What’s Available
Formulations through our 503A partner
Everything below is a prescription preparation, dispensed against a prescription written by a licensed provider for an individual patient. Availability of specific peptides depends on current FDA compounding status.
Compounded Hormone Preparations
Bioidentical estradiol, estriol, progesterone, and testosterone in formats commercial products do not offer.
- Transdermal creams and gels — avoids first-pass metabolism
- Oral micronized progesterone, commonly dosed at night
- Sublingual troches for combination preparations
- Vaginal creams, suppositories, and inserts for genitourinary symptoms
- Subcutaneous pellets for long-acting delivery
- Female-appropriate testosterone dosing — a fraction of male strengths
Peptides Studied in Women's Health Contexts
Peptides are not hormone replacement. They are studied for adjacent concerns that commonly accompany hormonal transitions.
- GHK-Cu for extracellular matrix and skin appearance research
- Growth hormone secretagogues studied for body composition and sleep depth
- DSIP and sleep-directed peptides for sleep quality
- PT-141 (bremelanotide) for hypoactive sexual desire disorder
- KPV for anti-inflammatory signaling research
Metabolic & Supporting Formulations
Metabolic dysfunction underlies a large share of what presents as a hormonal complaint.
- GLP-1 receptor agonist protocols where clinically appropriate
- Inositol and insulin-sensitizing supplement approaches for PCOS
- Thyroid support formulations
- Compounded topical anti-androgens for androgenic acne and alopecia
- Nutrient repletion — iron, vitamin D, B12 — where testing indicates
Peptide compounding status changes as FDA determinations are published. Check the FDA peptide status tracker for current standing.
How It Works
Evaluation first, then formulation
- 01
Provider evaluation
Symptom and menstrual history, personal and family history — particularly breast, cardiovascular, and thromboembolic — and a review of current medications.
- 02
Baseline testing
Hormone panel drawn at the correct cycle phase, plus thyroid, metabolic, and nutrient markers that commonly explain overlapping symptoms.
- 03
Individualized prescription
The provider specifies compound, strength, base, and delivery format. Our partner pharmacy prepares it to that specification.
- 04
Verification & dispensing
Preparations are compounded under USP 795 and 797 standards with analytical verification, then shipped with appropriate handling.
- 05
Follow-up & adjustment
Initial dosing is a starting point. Symptom response and repeat testing drive adjustment over the first several months.
FAQ
Common questions
Does Newtropin prescribe hormone therapy?
No. Newtropin is a nutraceutical and wellness marketing firm — not a pharmacy and not a clinic. We do not diagnose, prescribe, compound, or dispense. We connect healthcare providers with a licensed 503A compounding partner and support the sourcing and education side of that relationship. Patients access these preparations through their own provider.
What is the difference between compounded and commercial hormone therapy?
Commercial products are FDA-approved in fixed strengths and formats. Compounded preparations are made to an individual prescription, which allows non-standard doses, combined preparations, and alternative bases for patients who react to a commercial excipient. Compounded preparations are not FDA-approved as finished products, so the compounding pharmacy's quality standards matter considerably.
Can peptide therapy replace hormone therapy?
No. They address different things. Hormone therapy replaces declining estradiol, progesterone, or testosterone. Peptides are studied for adjacent concerns such as sleep quality, tissue integrity, and body composition. A provider may use them together, but one does not substitute for the other.
When should hormone therapy be started?
The literature supports a timing hypothesis: the risk-benefit balance of systemic hormone therapy is generally more favorable when started near the menopausal transition than many years afterward. This is an individualized clinical decision based on age, time since menopause, route, and personal and family history.
What testing is needed first?
Most providers order a hormone panel drawn at the appropriate cycle phase, plus thyroid studies, metabolic markers, CBC, and ferritin. The screening function matters as much as the hormonal picture — thyroid dysfunction, anemia, and metabolic disease all produce overlapping symptoms.
Are compounded preparations available in my state?
Our partner pharmacy is licensed to serve providers in all 50 states plus Washington, D.C. Availability of specific peptide preparations depends on current FDA compounding status, which changes as determinations are published.
What’s Next
Pair this with another Newtropin service
Every service is designed to fit together — round out your practice’s growth plan with one or more of the below.
Private Labeling
Rebrand existing formularies or develop custom blends.
Learn more →
Product Connections
1,000+ physician-grade nutraceuticals.
Learn more →
Wellness Marketing & Sales
Strategic marketing and sales support.
Learn more →
Physician Branding
Visual identity systems for medical practices.
Learn more →
SEO & Website Design
Full-service web development + managed SEO.
Learn more →
Compound Pharmacy
503A-licensed partner pharmacies.
Learn more →
Men's Health
Hormone optimization, recovery, and body composition.
Learn more →
Get In Touch
We Would Love To Hear From You
Send a message and our team will get back to you, typically within one business day. Clients may also call or email us directly.
- 866-206-1806
- customercare@newtropin.com
- 1615 S. Congress Ave, Delray Beach, FL 33445
Send us a message
For full contact form options, visit our contact page.
